31 Mar 2020
Assets87.85
Total Income201.24
Profit After Tax1.01
NET Worth12.31
Reserves and Surplus7.31
Total Borrowing19.71
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Revenue129.07₹ Cr · -22.3% vs prior year
PAT2.59₹ Cr · +77.4% vs prior year
Assets108.69₹ Cr · +41.2% vs prior year
Net Worth17.43₹ Cr · +17.5% vs prior year
Borrowing29.36₹ Cr · +15.2% vs prior year
3-year financial trendRevenue / EBITDA / PAT
₹ crore31 Mar 2021
Assets81.42
Total Income167.23
Profit After Tax1.08
NET Worth13.38
Reserves and Surplus8.39
Total Borrowing22.25
31 Mar 2022
Assets77.00
Total Income166.03
Profit After Tax1.46
NET Worth14.84
Reserves and Surplus9.85
Total Borrowing25.48
30 Sep 2022
Assets108.69
Total Income129.07
Profit After Tax2.59
NET Worth17.43
Reserves and Surplus12.44
Total Borrowing29.36
IPO UPDATE ALERTS
Register for IPO Updates →Track Aristo Bio-Tech and Lifescience without missing an update
Register for subscription, GMP, allotment and listing notifications.